European Foundation for the Study of Diabetes (EFSD)
and
sanofi-aventis
European Research Programme in Micro- and Macrovascular
Complications of Diabetes
Request for Applications
EFSD and sanofi-aventis
announce funding
of Research Grants in 2010
Deadline date: 15 March 2010
Background
The European Foundation for the Study of Diabetes (EFSD) was
created by the European Association for the Study of Diabetes (EASD) to provide
multiple funding initiatives in all areas of diabetes research. The aims of EFSD
are to encourage and support research in the field of diabetes, to rapidly
diffuse acquired knowledge and to facilitate its application.
The sanofi-aventis Group is one of
the world’s largest pharmaceutical companies. Backed by a world-class R&D
organisation, sanofi-aventis is developing leading positions in seven major
therapeutic areas. Their commitment to diabetes medicine has been longstanding
since 1923 and the involvement of Hoechst, a legacy company of sanofi-aventis.
Today sanofi-aventis produces several medicines to treat diabetes, including
insulin.
Programme Research and Focus
Applications to the Programme should address topics which are covered by the
programme’s headline ”EFSD/sanofi-aventis European Research Programme in Micro-
and Macrovascular Complications of Diabetes”. Grants will be awarded for basic
and clinical research focusing on vascular complications of diabetes.
Funding
The Programme will consider funding of basic
research projects up to Euro 100,000 in total for projects lasting up to
2 years, and clinical research projects up to Euro 400,000 in total for projects
lasting up to 3 years.
According to the duration and timetable of the projects, funds will be
made available annually.
Mechanism of Support and Review
Applications for an EFSD/sanofi-aventis grant are invited from single non-profit
institutions or groups of such institutions from Europe
or associated countries. The principal investigator and any co-investigators
must be normally employed at a non-profit institution and the study must be
performed at such a place of work.
Applications will be subject to scientific review by a
specialised ad hoc committee.
Funding will require approval by a joint EFSD and sanofi aventis Board convened
for this purpose. It is anticipated that applications will
be received, reviewed and approved for funding by June 2010.
The Programme Board, on advisement from the Review Committee, may on occasion,
and at its discretion, recommend an award in a different amount than requested
and that it considers more appropriate for the proposed studies.
Prior to any final decision on funding, and in order to
offer applicants the opportunity to benefit from the review process, EFSD
reserves the right to request revision to applications in accordance with the
recommendations of the Review Committee.
Research Grant Applications
Applications for research grants may be subjected to
pre-review (or triage) procedures. In this event, any application rejected at
pre-review will not be subject to a complete scientific review. The deadline for
receipt of research grant applications for funding this year is
15 March 2010.
All budgets are to be prepared in Euro. For countries in which
the Euro is not yet the common currency, the exchange rate (between the Euro and
the local currency in the country where the work is to be performed) used for
calculating the Euro budget must be mentioned under "Budget Justification".
Application forms
may be
downloaded here
All applications must be prepared on the official forms and
completed in strict accordance with the detailed instructions to be found on
these forms. In particular, applicants are reminded that any pages in addition
to the maximum of 10 allowed for the scientific section of the application will
be deleted prior to review. Similarly, no applications using a font or
line-spacing smaller than that defined in the instructions will be considered
for review. Additional material (in the form of an appendix, attachment,
reprints, etc.) will not be accepted.
Postal applications should be received in the EFSD Office no
later than 15 March 2010. Please send to:
European Foundation for the Study of Diabetes
Rheindorfer Weg 3
40591 Düsseldorf, Germany
Tel: +49-211-75 84 69 0
Fax: + 49-211-75 84 69 29
Review Considerations
Completed applications will be evaluated in accordance with the criteria stated below for scientific/technical
merit by an appropriate scientific committee convened by EFSD.
Review criteria are as follows:
- Significance: Does the study address an important problem in keeping with the goals and focus areas of this Programme? If the aims of the application are achieved, how will scientific knowledge be advanced? What will be the effect of the proposed studies on the concepts or methods that drive this field?
- Approach: Are the conceptual framework, design, methods and analyses adequately developed, well integrated, and appropriate to the aims of the project? Does the applicant acknowledge potential problem areas and consider alternative tactics?
- Innovation: Does the project employ novel concepts, approaches or methods? Are the aims original and innovative? Does the project challenge existing paradigms or develop new methodologies or technologies?
- Investigator: Is the investigator appropriately trained and well suited to carry out this work? Is the work proposed appropriate to the experience level of the principal investigator and other researchers, if any?
- Environment: Does the scientific environment in which the work will be done contribute to the probability of success? Do the proposed experiments take advantage of unique features of the scientific environment or employ useful collaborative arrangements? Is there evidence of institutional support?
- Budget: Is the requested budget appropriate for the proposed study?
Competitive
Renewal
Applications for a grant renewal grant will be accepted on a competitive basis,
with the same review process as described in this Announcement. Such
applications will thus be considered in the same fashion as all other new
applications received for review and without any special priority. Reporting Requirements
All investigators funded by this Programme are required to
submit a scientific progress report at the end of the project period. For those
projects where funding is distributed over a period of more than one year,
interim progress reports will also be required. Such reports will be subject to
assessment prior to the release of any further funds.
Investigators must provide EFSD with copies of papers accepted
for publication, and must acknowledge the support of the Programme in all
written material by use of the phrase: "supported by an
EFSD/sanofi-aventis research grant".
Schedule
| Announcement: |
December 2009 |
| Application Deadline: |
15 March 2010 |
| Anticipated Award: | June 2010 |
Enquiries should be directed to:
European Foundation for the Study of Diabetes
Rheindorfer Weg 3
40591 Düsseldorf, Germany
Tel: +49-211-75 84 69 0
Fax: + 49-211-75 84 69 29
E-mail: Foundation(a)easd.org
|
